Medifast (NYSE: MED) reported Q3 EPS of $3.56, $0.48 better than the analyst estimate of $3.08. Revenue for the quarter came in at $413.4 million versus the consensus estimate of $403.76 million.

For earnings history and earnings-related data on Medifast (MED) click here.